Our Consumer Healthcare business develops and markets consumer preferred and expert recommended brands in the Oral health, Pain relief, Respiratory, Nutrition/gastro-intestinal and Skin health categories. GSK’s Consumer Healthcare business is on track to become an independent company through a proposed demerger from GSK in mid-2022. The new business, to be named Haleon, is expected to be a world-leader in consumer healthcare, offering the prospect of attractive organic sales growth, operating margin expansion and consistent high cash generation. Learn more about the new Consumer Healthcare company.
We are one of the world’s leading over-the-counter healthcare companies. We hold number one positions in Wellness across 36 markets, and are market leaders in specialist oral care.
We have a portfolio of loved and trusted brands that are underpinned by science including: Sensodyne, Parodontax, Poligrip, Voltaren, Panadol, Otrivin and Theraflu.
The business generated sales of $10.1 billion in 2017, representing 26% of the total turnover of the Group.
Today, people are taking an increasingly active role in managing their own health. This is being fueled by an emerging global middle class, rising healthcare costs and ageing populations. Demand for consumer healthcare products is growing, particularly in emerging markets where consumers are seeking more affordable and accessible products.
Consumer healthcare products are dependent on brand loyalty and trademark protection. Some of our heritage brands such as Horlicks and ENO are more than 140 years old but continue to be popular today.
Our strategy is to meet the everyday healthcare needs of our consumers through building consumer preferred and expert recommended brands.
To do this we focus on excellence in innovation to develop world class brands, and on building our reputation through best in class interactions with retailers, healthcare professionals and shoppers.
Research for product innovation
Our business is built on science and this research heritage contributes to the development of our Consumer Healthcare products, giving us a unique advantage over our competition.
Today, we are using science to speed up the time to develop new product innovations, make them more accessible to the people who need them, and to develop benefits our consumers value, ultimately growing our business.
At the same time, we continue to ensure we meet all regulatory requirements for testing, approval, manufacturing, labelling and marketing of our products.
You can find out more about our R&D work on Consumer Healthcare products in our Research section.
If you have a product idea and believe we might like to partner with you, please visit our Consumer Healthcare External Innovation portal.
Other business areas
Our Pharmaceuticals business is made up of innovative and established medicines and holds leading market positions in respiratory disease and HIV.
Our Vaccines business has a broad portfolio and innovative pipeline of vaccines to protect people of all ages. We deliver over two million vaccine doses per day to people living in over 160 countries.
Find out more about us
GSK in the US
The US is home to ~15,000 GSK employees across 50 states, 9 manufacturing facilities and multiple R&D centers.
Our consumer healthcare products
When you experience discomforts like sensitive teeth, colds and flu or joint pain
Consumer healthcare research
GSK products are built around science, and it is this innovation that is vital to our Consumer Healthcare business